Herpes Simplex Infections – Pipeline Review, H1 2013 3/18/2013 \| published by: Global Markets Direct ... development for Herpes Simplex Infections, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Herpes Simplex Infections. Herpes Simplex Infections - ... \| read more...	$2,000.00
Hepatitis – Pipeline Review, H1 2013 3/18/2013 \| published by: Global Markets Direct ... with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Hepatitis. Hepatitis - Pipeline Review, Half Year is built using data and information ... \| read more...	$2,000.00
Chronic Obstructive Pulmonary Disease (COPD) – Pipeline Review, H1 2013 3/18/2013 \| published by: Global Markets Direct ... information on the therapeutic development for Chronic Obstructive Pulmonary Disease (COPD), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Chronic ... \| read more...	$2,000.00
Chemotherapy Induced Anemia – Pipeline Review, H1 2013 3/18/2013 \| published by: Global Markets Direct ... development for Chemotherapy Induced Anemia, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Chemotherapy Induced Anemia. Chemotherapy Induced Anemia - ... \| read more...	$2,000.00
Multiple Myeloma (Kahler's Disease) – Pipeline Review, H1 2013 3/18/2013 \| published by: Global Markets Direct ... the therapeutic development for Multiple Myeloma (Kahler's Disease), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Multiple Myeloma (Kahler's Disease). ... \| read more...	$2,000.00
Psoriasis – Pipeline Review, H1 2013 3/18/2013 \| published by: Global Markets Direct ... with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Psoriasis. Psoriasis - Pipeline Review, Half Year is built using data and information ... \| read more...	$2,000.00
Diabetes – Pipeline Review, H1 2013 3/18/2013 \| published by: Global Markets Direct ... with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Diabetes. Diabetes - Pipeline Review, Half Year is built using data and information ... \| read more...	$2,000.00
Metastatic Cancer – Pipeline Review, H1 2013 3/18/2013 \| published by: Global Markets Direct ... Metastatic Cancer, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Metastatic Cancer. Metastatic Cancer - Pipeline Review, Half Year is ... \| read more...	$2,000.00
Psoriatic Arthritis – Pipeline Review, H1 2013 3/18/2013 \| published by: Global Markets Direct ... Psoriatic Arthritis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Psoriatic Arthritis. Psoriatic Arthritis - Pipeline Review, Half Year is ... \| read more...	$2,000.00
Diabetic Foot Ulcers – Pipeline Review, H1 2013 3/18/2013 \| published by: Global Markets Direct ... development for Diabetic Foot Ulcers, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Diabetic Foot Ulcers. Diabetic Foot Ulcers - ... \| read more...	$2,000.00
Hypertension – Pipeline Review, H1 2013 3/18/2013 \| published by: Global Markets Direct ... with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Hypertension. Hypertension - Pipeline Review, Half Year is built using data and information ... \| read more...	$2,000.00
Mental Health Centres (UK) - Industry Report 3/18/2013 \| published by: Plimsoll Publishing Ltd. ... CARE (HIGHFIELD PARK) LTD and PASTORAL CYMRU LTD. This report covers activities such as mental health problems, challenging behaviour, mental health care, acquired brain injury, learning disabilities support and includes a wealth of information on ... \| read more...	$525.00
Prostate Cancer – Pipeline Review, H1 2013 3/18/2013 \| published by: Global Markets Direct ... Prostate Cancer, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Prostate Cancer. Prostate Cancer - Pipeline Review, Half Year is ... \| read more...	$2,500.00
Rheumatoid Arthritis – Pipeline Review, H1 2013 3/18/2013 \| published by: Global Markets Direct ... Rheumatoid Arthritis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Rheumatoid Arthritis. Rheumatoid Arthritis - Pipeline Review, Half Year is ... \| read more...	$2,500.00
Type 2 Diabetes – Pipeline Review, H1 2013 3/18/2013 \| published by: Global Markets Direct ... development for Type 2 Diabetes, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Type 2 Diabetes. Type 2 Diabetes - ... \| read more...	$2,500.00
Relapsing Remitting Multiple Sclerosis (RRMS) – Pipeline Review, H1 2013 3/18/2013 \| published by: Global Markets Direct ... information on the therapeutic development for Relapsing Remitting Multiple Sclerosis (RRMS), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Relapsing ... \| read more...	$2,000.00
Gastrointestinal Tract Cancer – Pipeline Review, H1 2013 3/18/2013 \| published by: Global Markets Direct ... development for Gastrointestinal Tract Cancer, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Gastrointestinal Tract Cancer. Gastrointestinal Tract Cancer - ... \| read more...	$2,000.00
Asthma – Pipeline Review, H1 2013 3/18/2013 \| published by: Global Markets Direct ... with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Asthma. Asthma - Pipeline Review, Half Year is built using data and information ... \| read more...	$2,000.00
Ocular Hypertension – Pipeline Review, H1 2013 3/18/2013 \| published by: Global Markets Direct ... Ocular Hypertension, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Ocular Hypertension. Ocular Hypertension - Pipeline Review, Half Year is ... \| read more...	$2,000.00
Malaria – Pipeline Review, H1 2013 3/18/2013 \| published by: Global Markets Direct ... with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Malaria. Malaria - Pipeline Review, Half Year is built using data and information ... \| read more...	$2,000.00
Type 1 Diabetes (Juvenile Diabetes) – Pipeline Review, H1 2013 3/18/2013 \| published by: Global Markets Direct ... information on the therapeutic development for Type 1 Diabetes (Juvenile Diabetes), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Type ... \| read more...	$2,000.00
Relapsed Multiple Myeloma – Pipeline Review, H1 2013 3/18/2013 \| published by: Global Markets Direct ... development for Relapsed Multiple Myeloma, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Relapsed Multiple Myeloma. Relapsed Multiple Myeloma - ... \| read more...	$2,000.00
Multiple Sclerosis – Pipeline Review, H1 2013 3/18/2013 \| published by: Global Markets Direct ... Multiple Sclerosis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Multiple Sclerosis. Multiple Sclerosis - Pipeline Review, Half Year is ... \| read more...	$2,000.00
Diabetic Neuropathy – Pipeline Review, H1 2013 3/18/2013 \| published by: Global Markets Direct ... Diabetic Neuropathy, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Diabetic Neuropathy. Diabetic Neuropathy - Pipeline Review, Half Year is ... \| read more...	$2,000.00
Neuropathic Pain – Pipeline Review, H1 2013 3/18/2013 \| published by: Global Markets Direct ... Neuropathic Pain, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Neuropathic Pain. Neuropathic Pain - Pipeline Review, Half Year is ... \| read more...	$2,000.00

< prev 2 3 4 5 6 7 8 9 10 11 next >